F2G

1 follower


F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

Industries

Headquarters

Stage

Employees

Links

Francesco Maria Lavino

Collapse
John H. Rex
Chief Medical Officer
Tony Kennedy
Chief Scientific & Development Officer
Janelle R. Anderson
Chief Business Officer
Mark Baglin
Chief Commercial Officer
Ana Zaccaro
Vice President Regulatory Affairs
daniela zinzi
VP, Clinical R&D
Dean Thompson
Head of Analytical Development
Kapil Sony
Head Of Formulation, CMC
Kristin Quinn
Associate Director, Regulatory CMC
Mark Bresnik, MD
Executive Director, Clinical R&D
Takara Leonard
Associate Director Regulatory Affairs
Karen Cornelissen
Director Early Clinical Development